Published in Jt Comm J Qual Improv on April 01, 2001
Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One (2013) 1.69
Identifying inference attacks against healthcare data repositories. AMIA Jt Summits Transl Sci Proc (2013) 0.83
Looking forward to impact: moving beyond serendipity. Health Serv Res (2002) 0.78
Localization of FtsI (PBP3) to the septal ring requires its membrane anchor, the Z ring, FtsA, FtsQ, and FtsL. J Bacteriol (1999) 4.87
Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol (1996) 4.02
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature (1994) 3.97
Use of phoA fusions to study the topology of the Escherichia coli inner membrane protein leader peptidase. J Bacteriol (1989) 2.38
Genetic analysis of the membrane insertion and topology of MalF, a cytoplasmic membrane protein of Escherichia coli. J Mol Biol (1988) 2.35
Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis (1986) 2.32
The effects of case definition in maternal screening and reporting criteria on rates of congenital syphilis. Am J Public Health (1990) 2.26
Health care abuse. CMAJ (1994) 2.22
Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol (1992) 2.13
Bms1p, a novel GTP-binding protein, and the related Tsr1p are required for distinct steps of 40S ribosome biogenesis in yeast. RNA (2001) 1.98
Molecular genetic analysis of membrane protein topology. Trends Genet (1988) 1.95
The haematology of hypothyroidism. Q J Med (1976) 1.93
Randomised trial of oral morphine for chronic non-cancer pain. Lancet (1996) 1.92
Genetic analysis of membrane protein topology by a sandwich gene fusion approach. Proc Natl Acad Sci U S A (1990) 1.89
Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem (1985) 1.88
Socioeconomic differences among people with AIDS: results from a Multistate Surveillance Project. Am J Prev Med (1995) 1.87
Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene (1999) 1.81
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci (1999) 1.68
A mutant hunt for defects in membrane protein assembly yields mutations affecting the bacterial signal recognition particle and Sec machinery. Proc Natl Acad Sci U S A (2000) 1.65
The topological analysis of integral cytoplasmic membrane proteins. J Membr Biol (1993) 1.63
Efficacy of albuterol in the management of bronchiolitis. Pediatrics (1994) 1.61
THE EFFECT OF MULTIPLE EMBOLI OF THE CAPILLARIES AND ARTERIOLES OF ONE LUNG. J Exp Med (1927) 1.59
FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy. Injury (2011) 1.58
An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim Biophys Acta (2002) 1.51
Effect of subarachnoid morphine administration on extubation time after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2000) 1.51
Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis (1995) 1.49
Influence of dental care on children's oral health and wellbeing. Br Dent J (2013) 1.42
Isolation of a replication origin complex from Escherichia coli. Proc Natl Acad Sci U S A (1980) 1.39
Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene (1997) 1.37
Quantitative bone mineral analysis using dual energy computed tomography. Invest Radiol (1978) 1.31
Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res (1998) 1.28
Risk behaviors of persons with heterosexually acquired HIV infection in the United States: results of a multistate surveillance project. J Acquir Immune Defic Syndr (1994) 1.28
Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Can J Infect Dis (1999) 1.28
Socio-economic and behavioural risk factors for tooth loss from age 18 to 26 among participants in the Dunedin Multidisciplinary Health and Development Study. Caries Res (2000) 1.23
Sleep in the laboratory and sleep at home II: comparisons of middle-aged insomnia sufferers and normal sleepers. Sleep (2001) 1.21
The dynamics of assembly of a cytoplasmic membrane protein in Escherichia coli. J Biol Chem (1992) 1.19
Reporting HIV infections. J Acquir Immune Defic Syndr (1994) 1.19
The ArcB sensor kinase of Escherichia coli: genetic exploration of the transmembrane region. J Bacteriol (2000) 1.18
Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res (1991) 1.15
Isolation and characterization of a cDNA clone for human ferritin heavy chain. Proc Natl Acad Sci U S A (1984) 1.15
Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer (1993) 1.13
Screening of Escherichia coli temperature-sensitive mutants by pretreatment with glucose starvation. J Bacteriol (1968) 1.12
Differential response to pain by very premature neonates. Pain (1995) 1.12
Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. J Clin Microbiol (2001) 1.10
Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res (1993) 1.09
An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur J Immunol (1996) 1.07
Perceptions of vaccine efficacy, illness, and health among inner-city parents. Clin Pediatr (Phila) (1993) 1.07
The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention. Am J Public Health (1994) 1.07
Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation. Cancer Res (1989) 1.06
The association between Porphyromonas gingivalis-specific maternal serum IgG and low birth weight. J Periodontol (2001) 1.06
In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene (1997) 1.05
Emergency department categorization: solid first steps. Acad Emerg Med (1999) 1.05
High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (2004) 1.05
Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J Biol Chem (1996) 1.04
Alterations in coagulation and fibrinolytic mechanisms in acute trauma. J Trauma (1969) 1.03
TnTIN and TnTAP: mini-transposons for site-specific proteolysis in vivo. Proc Natl Acad Sci U S A (1997) 1.03
Do provider practices conform to the new pediatric immunization standards? Arch Pediatr Adolesc Med (1994) 1.03
Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation. J Biol Chem (1988) 1.02
Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis. Gut (1991) 1.02
Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res (1995) 1.01
Ferritin H and L chains are derived from different multigene families. J Biol Chem (1985) 1.00
Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res (1993) 0.98
A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect Immun (2002) 0.97
Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis (2000) 0.97
Epithelioid hemangioendothelioma of the oral cavity: report of two cases and review of literature. J Oral Maxillofac Surg (1991) 0.96
Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur J Biochem (2000) 0.96
Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display. Cancer Commun (1990) 0.96
Factors that influence the behavioral pain responses of premature infants. Pain (1994) 0.95
Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biol Neonate (1999) 0.94
Developmental changes in response to heelstick in preterm infants: a prospective cohort study. Dev Med Child Neurol (1996) 0.94
Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. J Biol Chem (1995) 0.94
Human ferritin H and L sequences lie on ten different chromosomes. Hum Genet (1987) 0.93
The effect of ionic dissolution products of Ca-Sr-Na-Zn-Si bioactive glass on in vitro cytocompatibility. J Mater Sci Mater Med (2010) 0.92
Multidimensional pain assessment in premature neonates: a pilot study. J Obstet Gynecol Neonatal Nurs (1994) 0.92
Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme. Bull World Health Organ (1995) 0.92
Genetic selection for and molecular dynamic modeling of a protein transmembrane domain multimerization motif from a random Escherichia coli genomic library. J Mol Biol (2001) 0.91
Organ-site dependence for the production of urokinase-type plasminogen activator and metastasis by human renal cell carcinoma cells. Am J Pathol (1997) 0.90
Influence of venular prostaglandin release on arteriolar diameter during functional hyperemia. Hypertension (1998) 0.90
Propranolol in thyrotoxicosis: II. Serum thyroid hormone concentrations during subtotal thyroidectomy. Can J Surg (1979) 0.89
Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. Cancer Res (1996) 0.89
Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines. Thromb Haemost (1992) 0.89
A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor. Eur J Biochem (1999) 0.89
Aberrant cell division and random FtsZ ring positioning in Escherichia coli cpxA* mutants. J Bacteriol (1998) 0.89
Stress and inflammatory response after beating heart surgery versus conventional bypass surgery: the role of thoracic epidural anesthesia. Heart Surg Forum (2001) 0.89
Dimenhydrinate: evidence for dependence and tolerance. CMAJ (1988) 0.88
An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion. Laryngoscope (1998) 0.88
Quantitative aspects of computed tomography of the blood and cerebrospinal fluid. Radiology (1977) 0.87
The incidence of cleft lip and palate in Northern Ireland from 1980-1990. Br J Orthod (1994) 0.87
Regulation of the uPA gene in various grades of human glioma cells. Int J Oncol (2001) 0.87
Transcriptional activation of the urokinase receptor gene in invasive colon cancer. Int J Cancer (1994) 0.87
Organochlorine contaminant levels in Eskimo harvested bowhead whales of arctic Alaska. J Wildl Dis (1999) 0.87
Anonymous HIV testing: the impact of availability on demand in Arizona. Am J Public Health (1994) 0.86
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neurooncol (1994) 0.86
Comparison of an experimental bone cement with a commercial control, Hydroset. J Mater Sci Mater Med (2009) 0.85
Unusual sarcoma arising in lymphoedema. J R Soc Med (1985) 0.85
A mutational study of the ArcA-P binding sequences in the aldA promoter of Escherichia coli. Mol Gen Genet (1999) 0.85
Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. Cancer Res (2001) 0.85
Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium. Microb Pathog (1996) 0.85